Drug Pipeline News

Latest News

World’s first chikungunya vaccine FDA approved for individuals 18 years and up | Image Credit: © syahrir - © syahrir - stock.adobe.com.
World’s first chikungunya vaccine FDA approved for individuals 18 years and up

November 10th 2023

The US approval makes VLA1553 (Ixchiq; Valneva) the world’s first licensed chikungunya vaccine.

FDA grants De Novo clearance to Owlet’s Dream Sock: © Andrey - stock.adobe.com
FDA grants De Novo clearance to Owlet’s Dream Sock

November 9th 2023

Ustekinumab biosimilar approved for children 6 years and up with plaque psoriasis, psoriatic arthritis | Image Credit: © Calin- © Calin - stock.adobe.com.
Ustekinumab biosimilar approved for children 6 years and up with plaque psoriasis, psoriatic arthritis

November 7th 2023

Contemporary Pediatrics week in review: Infant mortality rates, FDA approvals, and more |  Image Credit: © Artur - © Artur - stock.adobe.com.
Contemporary Pediatrics week in review: Infant mortality rates, FDA approvals, and more

November 3rd 2023

FDA broadens abatacept usage to include psoriatic arthritis patients aged 2 years and older | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA broadens abatacept usage to include psoriatic arthritis patients aged 2 years and older

November 2nd 2023

Latest CME Events & Activities

2023 IASLC North America Conference on Lung Cancer Satellite Symposia

Register Now!

Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic

View More

Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Updates from the Annual Hematology Meeting: Matching the Tumor with Patient Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

View More

Bridging Clinical Gaps in Indolent and Aggressive B-Cell Lymphomas: The Investigators Demonstrate How Novel Mechanisms Will Impact Your Practice Tomorrow

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of CLL

View More

Expert Illustrations & Commentaries™: Emerging Strategies for the Treatment of Chronic Active Antibody-Mediated Rejection in Renal Transplant Recipients

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

Virtual Tumor Board®: Optimizing HER2 Testing Strategies for Clinical Decision Making in GI Malignancies

View More

(COPE Credit) MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

(CME/CNE Credit) MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm

View More

Sickle Cell Disease: Improving the Quality and Continuum of Acute and Ambulatory Patient Care

View More

Medical Crossfire®: Clinical Decision-Making Under New Paradigms for HR+/HER2- Breast Cancer

View More

Follicular Lymphoma Workshop: Forging Patient-Centric Plans with Targeted Therapies Across Lines of Care

View More

PER Postgame™: The Latest from Louisville 2022 – Utilizing Recent Data to Improve Care for Patients with Peanut Allergy

View More

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

View More

Advances In™ Desmoid Tumors: Recognizing Disease Burden, Pathophysiology, and Targeted Treatments in Development

View More

Gene Therapy for Hemophilia: What Does the Future Hold?

View More

Advances In™: Meeting Unmet Clinical Needs in TNBC and HR+ Breast Cancer with TROP2-Targeted Regimens

View More

Oncology Consultations®: Clinical Impact of HER2-Low Expressing Breast Cancer and Novel Targeted Therapies to Address Unmet Needs in Care

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

Medical Crossfire®: What Strategies Can the Care Team Implement to Optimize the Management of Pediatric Patients with NF1?

View More

Medical Crossfire®: How Do We Apply the Latest Evidence on Novel Therapies to Prevent and Treat GVHD?

View More

2nd Annual Hawaii Lung: A Multidisciplinary Case-Based Conference™

Register Now!

MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

View More

How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow

View More

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

View More

Community Practice Connections™: Visualizing New Treatment Pathways for Anemia in Chronic Kidney Disease

View More

More News

© 2023 MJH Life Sciences

All rights reserved.